Abstract
The antibacterial activities of a series of triazolyl oxazolidinones against Mycobacterium tuberculosis strain in vitro and in vivo in a mice model are presented. Most active compounds were noncytotoxic against VERO cells with acceptable selectivity indexes (SI) as measures of compound tolerability. Structure activity relationships (SARs) revealed that analogs with alkylcarbonyl (IC(90): < 0.2 to 0.422 μg/mL) and arylcarbonyl (IC(90): < 0.2 to 2.103 μg/mL) groups at the piperazine 4N-position-displayed potent antimycobacterium activities, comparable to the methanesulfonyl (IC(90): < 0.2 μg/mL) analog, linezolid (IC(90): < 0.2 μg/mL), and isoniazid (IC(90): < 0.034 μg/mL). The furanylcarbonyl derivative also displayed potent activity, while the arylsulfonyl analogs were inactive. Of the triazolyl oxazolidinones, the morpholino (PH-27) derivative with medium bioavailability in plasma was most active in vivo, but relatively less efficacious than isoniazid.
References
May 1, 1997·Antimicrobial Agents and Chemotherapy·L Collins, S G Franzblau
Dec 7, 2002·Bioorganic & Medicinal Chemistry·O A PhillipsN Al-Hassawi
Jan 22, 2005·Journal of Medicinal Chemistry·Folkert ReckMichael B Gravestock
May 25, 2005·Bioorganic & Medicinal Chemistry·Oludotun A PhillipsSanthosh M Samuel
Nov 11, 2006·Bioorganic & Medicinal Chemistry Letters·Sheila I HauckMichael B Gravestock
Dec 5, 2006·European Journal of Medicinal Chemistry·Oludotun A PhillipsSanthosh M Samuel
Feb 5, 2008·European Journal of Medicinal Chemistry·Oludotun A PhillipsSanthosh M Samuel
Feb 20, 2008·Bioorganic & Medicinal Chemistry·Umashankar DasJonathan R Dimmock
Oct 9, 2008·Drug Discovery Today·Emma C Rivers, Ricardo L Mancera
Dec 2, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G F SchecterS Mase
Jun 5, 2010·Future Microbiology·Alberto MatteelliAfranio Kritski
Sep 28, 2010·Expert Opinion on Emerging Drugs·Wing Wai YewYing Zhang
Dec 17, 2010·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Oludotun A PhillipsReny Varghese
Jan 29, 2011·Nature·Anil KoulKoen Andries